Loading live market data…

BioAtla, Inc.

NASDAQ:BCAB

$4.26 USD

$0.2 (4.93%)

Volume
39.12K
Average Volume
51.71K
Market Capitalization
$5.37M
P/E Ratio
-0.10
Dividend Yield
0.00%
Price Target
$250.00
Year High
$71.50
Year Low
$3.12
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.15
Source Headline
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

Context announces buyout of CT-202 future milestones and royalties in exchange for a fully paid-up, non-terminable license

globenewswire.com - 2026-05-18 06:45:00

Get BCAB Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

BCAB Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$250.00

1 analysts

BCAB Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-08-13 JMP Securities Downgrade Market Outperform Market Perform
2025-03-31 HC Wainwright & Co. Maintain Neutral Neutral
2025-03-31 Citizens Capital Markets Maintain Market Outperform Market Outperform
2024-11-13 HC Wainwright & Co. Downgrade Buy Neutral
2024-09-16 JMP Securities Maintain Market Outperform Market Outperform
2024-05-23 JMP Securities Maintain Market Outperform Market Outperform
2024-05-15 HC Wainwright & Co. Maintain Buy Buy
2024-03-28 JMP Securities Maintain Market Outperform Market Outperform
2024-03-27 HC Wainwright & Co. Maintain Buy Buy
2023-12-05 JMP Securities Maintain Market Outperform Market Outperform
2023-11-08 HC Wainwright & Co. Maintain Buy Buy
2023-09-25 JP Morgan Maintain Overweight Overweight
2023-08-02 HC Wainwright & Co. Maintain Buy Buy
2023-08-02 JP Morgan Maintain Overweight Overweight
2023-08-02 JMP Securities Maintain Market Outperform Market Outperform
2023-08-02 EF Hutton Maintain Buy Buy
2023-05-15 HC Wainwright & Co. Maintain Buy Buy
2023-05-15 JMP Securities Maintain Outperform Outperform
2023-05-12 EF Hutton Maintain Buy Buy
2023-04-17 EF Hutton Maintain Buy Buy
2023-04-03 JP Morgan Maintain Overweight Overweight
2023-03-28 BTIG Maintain Buy Buy
2023-03-27 JMP Securities Maintain Outperform Outperform
2023-03-24 Credit Suisse Maintain Neutral Neutral
2023-03-24 HC Wainwright & Co. Maintain Buy Buy
2023-01-05 EF Hutton Maintain Buy Buy
2022-11-04 Credit Suisse Maintain Neutral Neutral
2022-09-15 JMP Securities Maintain Market Outperform Outperform
2022-08-10 Credit Suisse Maintain Neutral Neutral
2022-08-10 HC Wainwright & Co. Maintain Buy Buy
2022-05-05 Credit Suisse Downgrade Outperform Neutral
2022-03-21 HC Wainwright & Co. Maintain Buy Buy
2021-06-28 Roth Capital Maintain Buy Buy
2021-03-26 BTIG Maintain Buy Buy
2021-01-11 Credit Suisse Maintain Outperform Outperform
2021-01-11 Jefferies Maintain Buy Buy
2021-01-11 BTIG Maintain Buy Buy
2021-01-11 JP Morgan Maintain Overweight Overweight